Home

Oncobell is a joint research program focused on molecular mechanisms and experimental therapies in cancer. It is a new program within the IDIBELL with the aim to fight cancer in a collective and multidisciplinary way. It includes an array of groups that cover the stages from basic frontier research all the way to clinical treatments of the patients. 

The common nominator of the program is that all groups work on improving patients’ outcomes through either a molecular/pathway oriented approach or through a disease and clinical needs oriented approach.  We believe that increasing the communication between groups linking these two approaches will lead to better ideas and shortcuts in the transition between lab results into the clinics.

2nd International Symposium:   “Building bridges between science, cancer medicine and persons

The second Oncobell symposium will be a forum to discuss basic and clinical advances in cancer research with outstanding professionals.

 
Reproducir vídeo
Isabel Fabregat

TGF-Beta and Cancer Group, Oncobell Program, IDIBELL – UB – CIBERehd, Barcelona

Ferran Guedea

Radiobiology & Cancer  Group, Oncobell Program, IDIBELL – ICO, Barcelona

Purificación Muñoz

Ageing and Cancer Group, Oncobell Program,    IDIBELL, Barcelona

Cristina Muñoz-Pinedo

Cell Death Regulation Group, Oncobell Program, IDIBELL – UB, Barcelona

Josep Mª Piulats

       Clinical Research in Solid Tumors (CREST) Group, Oncobell Program, IDIBELL – ICO, Barcelona

Jordi Ponce

Gynecologic Cancer Group, Oncobell Program, IDIBELL – HUB, Barcelona

Javier Márquez

Administrative Support, Oncobell Program, IDIBELL, Barcelona

Antonio Gentilella  

Metabolism and Cancer Group, Oncobell Program, IDIBELL – UB, Barcelona

Óscar Martínez-Tirado  

Sarcoma Research Group, Oncobell Program, IDIBELL, Barcelona

Ernest Nadal 

Preclinical and Experimental Research in Thoracic Tumors Group, Oncobell Program, IDIBELL – ICO, Barcelona

Cristina Santos  

Colorectal Cancer Group, Oncobell Program, IDIBELL – ICO, Barcelona